Thornton Michael Milos

SEC source: 0001209191-23-031298 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,139

SEC source: 0001209191-23-006047 · doc4.xml · derivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,066

Underlying: Common Stock · 68,066 shares

Expires 2033-01-30

F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024.

SEC source: 0001209191-22-060895 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,139

F1 · balance_after: On December 9, 2022, the Issuer effected a 1-for-20 reverse stock split (the "Reverse Stock Split") of its outstanding Common Stock. The number of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.

SEC source: 0001209191-22-047298 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,775

SEC source: 0001209191-22-032746 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,775

SEC source: 0001209191-22-031319 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,775

SEC source: 0001209191-22-021624 · doc4.xml · derivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 698,102

Underlying: Common Stock · 698,102 shares

Expires 2032-03-28

F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023.

SEC source: 0001209191-21-025846 · doc4.xml · nonDerivative · entry 2

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,960

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.56, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-21-025846 · doc4.xml · derivative · entry 3

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-04-05

F4 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022.

SEC source: 0001209191-21-025846 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,960

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.35 to $2.39, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-21-029290 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 316,525

F1 · shares: Represents restricted stock units paid as a 2020 annual bonus by the Issuer to the Reporting Person, which fully vested upon grant.

SEC source: 0001209191-21-057234 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 316,525

SEC source: 0001209191-20-042615 · doc4.xml · derivative · entry 2

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,252

Underlying: Common Stock · 26,000 shares

Expires 2024-12-11

SEC source: 0001209191-20-042615 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,710

F1 · balance_after: Includes unvested restricted stock units.

SEC source: 0001209191-20-035437 · doc4.xml · derivative · entry 2

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 51,747 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Series A Convertible Preferred Stock has a face value of $1,000 per share and accrues dividends thereon at an annual rate of 6.0%. The face value plus accrued and unpaid dividends of the Series A Convertible Preferred Stock is convertible into common stock at a price per share of $0.87.

F3 · derivative.expiration_date: The Series A Convertible Preferred Stock has no expiration date.

SEC source: 0001209191-20-035437 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,710

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes unvested restricted stock units.

SEC source: 0001209191-20-024211 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,963

F1 · shares: Represents restricted stock units granted in lieu of a portion of the Reporting Person's cash salary. Subject to continued employment, the restricted stock units vest each day, pro rata based on the number of days between the grant date and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes unvested restricted stock units.

SEC source: 0001209191-19-060091 · doc4.xml · derivative · entry 3

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,252

Underlying: Common Stock · 50,252 shares

Expires 2024-12-11

F4 · price: The Warrants were issued for no additional consideration in connection with the purchase of the Series A preferred stock.

SEC source: 0001209191-19-060091 · doc4.xml · derivative · entry 2

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43.719

Underlying: Common Stock · 50,252 shares

Expires not disclosed

F2 · derivative.exercise_price: The Series A preferred stock has a face value of $1,000 per share and accrues dividends thereon at an annual rate of 6.0%. The face value plus accrued and unpaid dividends of the Series A preferred stock is convertible into common stock at a price per share of $0.87.

F3 · derivative.expiration_date: The Series A preferred stock has no expiration date.

SEC source: 0001209191-19-060091 · doc4.xml · derivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 575,906

Underlying: Common Stock · 575,906 shares

Expires 2029-12-11

F1 · derivative.exercise_date: These options vest and become exercisable in three equal annual installments beginning on the one year anniversary of the grant date.

SEC source: 0001209191-19-031215 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,750

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.09 to $1.19, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

SEC source: 0001209191-18-062950 · doc4.xml · derivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2026-12-13

F1 · derivative.exercise_date: These Stock Options become exercisable in three equal annual installments beginning on December 13, 2019.

SEC source: 0001209191-18-058720 · doc4.xml · derivative · entry 2

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · 29,762 shares

Expires 2018-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Pursuant to the terms of the Convertible Promissory Note (the "Note"), the principal amount of the Note automatically converted into shares of the Issuer's Common Stock upon the consummation of a Qualified Financing (as defined in the Note) at the lowest per share price at which Common Stock was sold by the Issuer in the Qualified Financing, less a discount of 20%.

SEC source: 0001209191-18-058720 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These shares of Common Stock were issued upon the conversion of the Convertible Promissory Note described in footnote (2).

SEC source: 0001209191-18-040508 · doc4.xml · derivative · entry 2

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,401

Underlying: Common Stock · 12,401 shares

Expires 2021-06-28

F4 · price: The Warrants were issued for no additional consideration in connection with the offer and sale of the Note.

SEC source: 0001209191-18-040508 · doc4.xml · derivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · 24,802 shares

Expires 2018-12-31

F1 · derivative.exercise_price: The Convertible Promissory Note (the "Note") is convertible into the Issuer's common stock at a conversion price equal to the lesser of (a) the lowest per share price at which common stock is sold by the Issuer in a sale resulting in aggregate gross cash proceeds of at least $7.0 million (a "Qualified Financing"), less a discount of 20%, or (b) $2.016, but in any event no less than a conversion price floor of $1.40, which conversion price is subject to adjustment in certain circumstances in accordance with the terms of the Note.

F2 · derivative.exercise_date: The principal amount of the Note will automatically convert into shares of the Issuer's common stock (i) upon the consummation of a Qualified Financing or (ii) if the holders of a majority of the aggregate principal amount of outstanding Convertible Promissory Notes elect to convert such notes at any time until three days prior to a Qualified Financing. Additionally, the reporting person is entitled to convert the principal amount of the Note into common stock (i) at any time until three days prior to the consummation of a Qualified Financing or (ii) if a material Event of Default (as defined in the Note) shall have occurred and be continuing. In each case, conversion is subject to the terms and provisions of the Note.

F3 · derivative.underlying_shares: The number of shares of common stock shown in Column 7 assumes a conversion price of $2.016, which is subject to adjustment in certain circumstances (see Footnote 1).

SEC source: 0001209191-17-039508 · doc4.xml · derivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,960

Underlying: Common Stock · 31,960 shares

Expires 2022-05-12

F1 · derivative.exercise_date: These Stock Options become exercisable in three equal annual installments beginning on May 12, 2018.

SEC source: 0001209191-17-042113 · doc4a.xml · derivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,960

Underlying: Common Stock · 31,960 shares

Expires 2025-05-12

F1 · derivative.exercise_date: These Stock Options become exercisable in three equal annual installments beginning on May 12, 2018.

F2 · derivative.expiration_date: This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.

SEC source: 0001209191-17-032896 · doc4.xml · derivative · entry 3

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,338

Underlying: Common Stock · 313,338 shares

Expires 2022-05-12

F3 · derivative.exercise_date: These Stock Options become exercisable in three equal annual installments beginning on May 12, 2018.

SEC source: 0001209191-17-032896 · doc4.xml · derivative · entry 2

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2017-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The principal amount of, and accrued interest on, the Convertible Promissory Note converted into shares of Common Stock of the Issuer at a conversion price of $1.40 per share immediately prior to the consummation of the Issuer's initial public offering.

SEC source: 0001209191-17-032896 · doc4.xml · nonDerivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,987

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These shares of Common Stock were issued upon the conversion of the Convertible Promissory Note, as described in footnote (2).

SEC source: 0001209191-17-034733 · doc4a.xml · derivative · entry 1

Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,338

Underlying: Common Stock · 313,338 shares

Expires 2025-05-12

F1 · derivative.exercise_date: These Stock Options become exercisable in three equal annual installments beginning on May 12, 2018.

F2 · derivative.expiration_date: This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.